Alexza Pharmaceuticals Inc. (NASDAQ: ALXA) resumes trading and is up 45% following a licensing deal with Teva Pharmaceutical ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE